Journal article · 2021 · Open access

PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial

Maria Margarete Karsten, Friedrich Kühn, Therese Pross, Jens‐Uwe Blohmer, Anna Maria Hage, Felix H. Fischer, Matthias Rose, Ulrike Grittner, Pimrapat Gebert, Julia Ferencz, Luis Pauler, Clara Breidenbach and 8 more

Trials, 22(1), 666 · Published 28 September 2021 · DOI 10.1186/s13063-021-05642-6

Open PDFView at the publisherCite this paper

In brief

“PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial” is a 2021 journal article by Maria Margarete Karsten and 19 co-authors, published in Trials. OpenAlex counts 37 citations as of 22 November 2026, which puts it in the top 6% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at Trials.

Citations
37
Most cited in
2024 (12)
Field-weighted impact
2.11
References
26
Authors
20

Abstract

BACKGROUND: Despite the progress of research and treatment for breast cancer, still up to 30% of the patients afflicted will develop distant disease. Elongation of survival and maintaining the quality of life (QoL) become pivotal issues guiding the treatment decisions. One possible approach to optimise survival and QoL is the use of patient-reported outcomes (PROs) to timely identify acute disease-related burden. We present the protocol of a trial that investigates the effect of real-time PRO data captured with electronic mobile devices on QoL in female breast cancer patients with metastatic disease. METHODS: This study is a randomised, controlled trial with 1:1 randomisation between two arms. A total of 1000 patients will be recruited in 40 selected breast cancer centres. Patients in the intervention arm receive a weekly request via an app to complete the PRO survey. Symptoms will be assessed by study-specific optimised short forms based on the EORTC QLQ-C30 domains using items from the EORTC CAT item banks. In case of deteriorating PRO scores, an alarm is sent to the treating study centre as well as to the PRO B study office. Following the alarm, the treating breast cancer centre is required to contact the patient to inquire about the reported symptoms and to intervene, if necessary. The intervention is not specified and depends on the clinical need determined by the treating physician. Patients in the control arm are prompted by the app every 3 months to participate in the PRO survey, but their response will not trigger an alarm. The primary outcome is the fatigue level 6 months after enrolment. Secondary endpoints include among others hospitalisations, use of rescue services and overall QoL. DISCUSSION: Within the PRO B intervention group, we expect lower fatigue levels 6 months after intervention start, higher levels of QoL, less unplanned hospitalisations and less emergency room visits compared to controls. In case of positive results, our approach would allow a fast and easy transfer into clinical practice due to the use of the already nationwide existing IT infrastructure of the German Cancer Society and the independent certification institute OnkoZert. TRIAL REGISTRATION: DRKS (German Clinical Trials Register) DRKS00024015 . Registered on 15 February 2021.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Karsten, M. M., Kühn, F., Pross, T., Blohmer, J., Hage, A. M., Fischer, F. H., Rose, M., Grittner, U., Gebert, P., Ferencz, J., Pauler, L., Breidenbach, C., Kowalski, C., Board, O. B. O. T. P. B. S., Matthesius, G., Seemann, J., Lenz, J., Rocabado, S., Du Bois, M., & Straubing, L. (2021). PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial. Trials, 22(1), 666. https://doi.org/10.1186/s13063-021-05642-6

MLA 9

Karsten, Maria Margarete, et al. “PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial.” Trials, vol. 22, no. 1, 2021, p. 666. https://doi.org/10.1186/s13063-021-05642-6.

Chicago

Karsten, Maria Margarete, Friedrich Kühn, Therese Pross, Jens‐Uwe Blohmer, Anna Maria Hage, Felix H. Fischer, Matthias Rose, et al. 2021. “PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial.” Trials 22 (1): 666. https://doi.org/10.1186/s13063-021-05642-6.

Harvard

Karsten, M. M. et al. (2021) ‘PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial’, Trials, 22(1), p. 666. doi:10.1186/s13063-021-05642-6.

IEEE

M. M. Karsten et al., “PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial,” Trials, vol. 22, no. 1, p. 666, 2021, doi: 10.1186/s13063-021-05642-6.

BibTeX

@article{karsten2021evaluating,
  title     = {{PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial}},
  author    = {Karsten, Maria Margarete and Kühn, Friedrich and Pross, Therese and Blohmer, Jens‐Uwe and Hage, Anna Maria and Fischer, Felix H. and Rose, Matthias and Grittner, Ulrike and Gebert, Pimrapat and Ferencz, Julia and Pauler, Luis and Breidenbach, Clara and Kowalski, Christoph and Board, on behalf of the PRO B Steering and Matthesius, G and Seemann, Jannis and Lenz, Jennifer and Rocabado, Sophia and Du Bois, Marlen and Straubing, Lars},
  journal   = {Trials},
  year      = {2021},
  volume    = {22},
  number    = {1},
  pages     = {666},
  doi       = {10.1186/s13063-021-05642-6},
  url       = {https://doi.org/10.1186/s13063-021-05642-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202233
202388
20241212
202588
202666

Its field-weighted citation impact is 2.11: it has been cited 2.11 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • metastatic breast cancer
  • patient-reported outcomes
  • mobile health apps
  • real-time symptom monitoring
  • alarm system
  • quality of life
  • fatigue
  • EORTC QLQ-C30

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Karsten, M. M., Kühn, F., Pross, T., Blohmer, J., Hage, A. M., Fischer, F. H., Rose, M., Grittner, U., Gebert, P., Ferencz, J., Pauler, L., Breidenbach, C., Kowalski, C., Board, O. B. O. T. P. B. S., Matthesius, G., Seemann, J., Lenz, J., Rocabado, S., Du Bois, M., & Straubing, L. (2021). PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial. Trials, 22(1), 666. https://doi.org/10.1186/s13063-021-05642-6

How many times has this paper been cited?

37 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Trials: sign in and open the PDF from this page.

Who wrote this paper?

Maria Margarete Karsten, Friedrich Kühn, Therese Pross, Jens‐Uwe Blohmer, Anna Maria Hage, Felix H. Fischer, Matthias Rose, Ulrike Grittner, Pimrapat Gebert, Julia Ferencz, Luis Pauler, Clara Breidenbach and 8 more.

What is the DOI of this paper?

10.1186/s13063-021-05642-6, permanently at https://doi.org/10.1186/s13063-021-05642-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.